Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Total Non-Current Liabilities (2022 - 2026)

Moolec Science (MLECW) posted Total Non-Current Liabilities of $93.1 million for Q1 2026, up 253.61% sequentially from $26.3 million in Q4 2025.

Moolec Science (MLECW) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Moolec Science has reported Total Non-Current Liabilities for 5 years, with the latest figure at $93.1 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities changed N/A year-over-year to $93.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.1 million (changed N/A YoY) and the FY2025 annual result came in at $53.1 million, down 80.53% from the prior year.
  • Total Non-Current Liabilities advanced to $93.1 million in Q1 2026 per MLECW's latest filing, from $26.3 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $272.4 million in Q2 2024 and troughed at $621000.0 in Q2 2022.
  • A 5-year average of $44.1 million and a median of $19.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities surged 8858.23% in 2023, then sank 80.53% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $9.6 million in 2022, then tumbled by 33.88% to $6.4 million in 2023, then surged by 248.16% to $22.1 million in 2024, then increased by 18.99% to $26.3 million in 2025, then jumped by 253.61% to $93.1 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $93.1 million, $26.3 million, and $53.1 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 40.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 3.92 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.88 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 724.15 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.17 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.32 Bn
10 Moolec Science 8,617.72 -1.19 Mn - 93.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.10 Mn
Dec 31, 2025 26.33 Mn
Jun 30, 2025 53.05 Mn
Dec 31, 2024 22.13 Mn
Sep 30, 2024 19.50 Mn
Jun 30, 2024 272.43 Mn
Mar 31, 2024 11.49 Mn
Dec 31, 2023 6.36 Mn
Sep 30, 2023 1.09 Mn
Jun 30, 2023 55.63 Mn
Mar 31, 2023 1.59 Mn
Dec 31, 2022 9.61 Mn
Jun 30, 2022 621,000.00